Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen Moves into a New Phase--and New Headquarters

SAN FRANCISCO, Jan. 10 - Perlegen Sciences' recent move to new facilities dovetails with the gene-to-phenotype association studies it is gearing up to begin, said Jesse Hsu, the company's director of corporate development.

 

In December the company moved from Santa Clara, Calif., into a 60,000-square-foot building in Mountain View, Calif. The new building has approximately half the space dedicated to a wet lab and the other half to computer facilities, Hsu told attendees of the 20th annual JPMorgan H&Q Healthcare Conference, which ends today.

 

The wet lab will be used over the next few months to begin DNA analysis of human blood samples for association studies that Perlegen has planned. The studies represent the second phase in the company's progression towards finding gene targets associated with disease, said Hsu. The first phase—haplotype mapping—will be finished around August, according to Hsu.

 

Hsu estimates the company will have its first gene targets toward the beginning of 2003. Perlegen plans to sell targets and to work to understand their biology to go further down the line towards drug development. "We have to eat while we grow," Hsu said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.